A recent study revealed that FOXA1 expression is negatively correlated with interferon activity and the INF-response gene expression signature in luminal breast cancer, suggesting that FOXA1 suppresses the immune response in this disease [162]. The gene discussed is FOXA1; the disease is breast carcinoma.